Information:
Error:
ID
34393
Description
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Unfavourable Somatic Status; ODM derived from: https://clinicaltrials.gov/show/NCT01283386
Link
https://clinicaltrials.gov/show/NCT01283386
Keywords
Versions (1)
- 1/17/19 1/17/19 -
Copyright Holder
GSK group of companies
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
- StudyEvent: Eligibility
Similar models
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
adult patients, 60-70 or >70 years of age
boolean
ID.2
Item
cumulative illness rating scale (cirs) comorbidity score >/=7 if patient is 60-70 years old
boolean
ID.3
Item
previously untreated b-cell chronic lymphocytic leukemia
boolean
ID.4
Item
binet stage b, c or a with progression
boolean
ID.5
Item
ecog performance status 0-2
boolean
ID.6
Item
small-cell lymphoma
boolean
ID.7
Item
autoimmune hemolytic anemia
boolean
ID.8
Item
concomitant malignant disease during enrollment, except for basal cell carcinoma of the skin
boolean
ID.9
Item
chemotherapy for concomitant malignant disease within 12 months prior to study enrollment
boolean
ID.10
Item
richter's syndrome
boolean